Free Trial

Tectonic Therapeutic (TECX) Stock Forecast & Price Target

$15.90
-0.57 (-3.46%)
(As of 07/1/2024 ET)

Tectonic Therapeutic - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Consensus Price Target

$76.00
377.99% Upside
High Forecast$76.00
Average Forecast$76.00
Low Forecast$76.00
TypeCurrent Forecast
7/2/23 to 7/1/24
1 Month Ago
6/2/23 to 6/1/24
3 Months Ago
4/3/23 to 4/2/24
1 Year Ago
7/2/22 to 7/2/23
Consensus Rating
Buy
N/AN/AN/A
Strong Buy
0 Strong Buy rating(s)
N/A N/A N/A
Buy
2 Buy rating(s)
N/A N/A N/A
Hold
0 Hold rating(s)
N/A N/A N/A
Sell
0 Sell rating(s)
N/A N/A N/A
Consensus Price Target$76.00N/AN/AN/A
Forecasted Upside377.99% UpsideN/AN/AN/A
Get Tectonic Therapeutic Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for TECX and its competitors with MarketBeat's FREE daily newsletter.

TECX Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

TECX Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Tectonic Therapeutic Stock vs. The Competition

TypeTectonic TherapeuticMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.70
2.50
Consensus RatingBuyModerate BuyModerate Buy
Predicted Upside361.45% Upside794.98% Upside11.51% Upside
News Sentiment RatingPositive News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/26/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Y. Rahimi
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$76.00+375.89%
6/24/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 06:18 PM ET.

TECX Forecast - Frequently Asked Questions

What is Tectonic Therapeutic's stock forecast and purchase recommendation?

According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Tectonic Therapeutic is $76.00, with a high forecast of $76.00 and a low forecast of $76.00. The consensus rating for Tectonic Therapeutic stock is Buy based on the current 2 buy ratings for TECX. Learn more on TECX's analyst rating history.

Do Wall Street analysts like Tectonic Therapeutic more than its competitors?

Analysts like Tectonic Therapeutic more than other "medical" companies. The consensus rating for Tectonic Therapeutic is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how TECX compares to other companies.

Does Tectonic Therapeutic's stock price have much upside?

According to analysts, Tectonic Therapeutic's stock has a predicted upside of 375.89% based on their 12-month stock forecasts.

What analysts cover Tectonic Therapeutic?

Tectonic Therapeutic has been rated by research analysts at Piper Sandler, and TD Cowen in the past 90 days.


This page (NASDAQ:TECX) was last updated on 7/1/2024 by MarketBeat.com Staff

From Our Partners